BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11948692)

  • 1. Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells.
    Kim EJ; Lee JM; Namkoong SE; Um SJ; Park JS
    J Cell Biochem; 2002; 85(2):369-80. PubMed ID: 11948692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3.
    Sato T; Selleri C; Young NS; Maciejewski JP
    Blood; 1997 Dec; 90(12):4749-58. PubMed ID: 9389691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes.
    Kano A; Haruyama T; Akaike T; Watanabe Y
    Biochem Biophys Res Commun; 1999 Apr; 257(3):672-7. PubMed ID: 10208842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53.
    Um SJ; Kim EJ; Hwang ES; Kim SJ; Namkoong SE; Park JS
    Int J Cancer; 2000 Feb; 85(3):416-23. PubMed ID: 10652435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of IFN-gamma-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells.
    Connett JM; Hunt SR; Hickerson SM; Wu SJ; Doherty GM
    J Interferon Cytokine Res; 2003 Nov; 23(11):621-30. PubMed ID: 14651776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IRF-1 and caspase-7 in IFN-gamma enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells.
    Tomita Y; Bilim V; Hara N; Kasahara T; Takahashi K
    Int J Cancer; 2003 Apr; 104(4):400-8. PubMed ID: 12584735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
    Yim JH; Ro SH; Lowney JK; Wu SJ; Connett J; Doherty GM
    J Interferon Cytokine Res; 2003 Sep; 23(9):501-11. PubMed ID: 14565859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
    Sancéau J; Hiscott J; Delattre O; Wietzerbin J
    Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1.
    Sato T; Selleri C; Young NS; Maciejewski JP
    Blood; 1995 Nov; 86(9):3373-80. PubMed ID: 7579440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.
    Burke F; Smith PD; Crompton MR; Upton C; Balkwill FR
    Br J Cancer; 1999 Jun; 80(8):1236-44. PubMed ID: 10376977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma enhances TRAIL-induced apoptosis through IRF-1.
    Park SY; Seol JW; Lee YJ; Cho JH; Kang HS; Kim IS; Park SH; Kim TH; Yim JH; Kim M; Billiar TR; Seol DW
    Eur J Biochem; 2004 Nov; 271(21):4222-8. PubMed ID: 15511228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells.
    Horiuchi M; Yamada H; Akishita M; Ito M; Tamura K; Dzau VJ
    Hypertension; 1999 Jan; 33(1):162-6. PubMed ID: 9931097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA.
    Harroch S; Revel M; Chebath J
    EMBO J; 1994 Apr; 13(8):1942-9. PubMed ID: 8168491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 1 mediates the interferon-gamma induction of the human immunoproteasome subunit multicatalytic endopeptidase complex-like 1.
    Foss GS; Prydz H
    J Biol Chem; 1999 Dec; 274(49):35196-202. PubMed ID: 10575004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
    Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
    J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma inhibits growth of human neuroendocrine carcinoma cells via induction of apoptosis.
    Detjen KM; Kehrberger JP; Drost A; Rabien A; Welzel M; Wiedenmann B; Rosewicz S
    Int J Oncol; 2002 Nov; 21(5):1133-40. PubMed ID: 12370765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
    Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
    J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.